At Encore Biomedicals, our legacy in the diagnostics field spans over two decades, making us pioneers in the realm of healthcare solutions. Established by a team of dedicated professionals with a collective experience of 20-25 years in the diagnostics industry, we have consistently strived to redefine healthcare accessibility and innovation.
With a deep-seated commitment to delivering superior diagnostics solutions, our four visionary directors embarked on a journey in 2022, determined to revolutionise the diagnostics landscape in India. Our extensive experience and unwavering dedication have propelled us to the forefront of the industry.
Encore Biomedicals proudly holds the distinction of being the first company to introduce online selling of Rapid and ELISA Kits in India. This pioneering approach has streamlined the process of procuring critical diagnostic tools, ensuring that they reach pathology labs and hospitals efficiently and promptly. Our direct-from-manufacturer model ensures that these vital diagnostic resources are readily available, empowering healthcare professionals to deliver swift and accurate diagnoses.
Accelerated results for an onerous situation
Cost effective solutions for every individual across the globe
A keen eye to detect the problem in any complex structure
Sickle cell disease is a hereditary blood disorder affecting millions worldwide. With its roots deeply embedded in genetics, early detection and effective management are critical in providing better quality of life for those affected. In this pursuit, rapid testing kits have emerged as a beacon of hope, transforming the landscape of sickle cell.
In the dynamic landscape of healthcare, lab owners are continually seeking innovative solutions to enhance efficiency, accuracy, and overall performance. The advent of RAPISCAN Rapid Test Reading App through Mobile Cameras has emerged as a transformative tool, presenting numerous benefits to lab owners.
STAY UPDATED TO ALL THE LATEST NEWS AND OFFERS AT ENCORE
